Lataa...
Effect of the Glucagon‐like Peptide‐1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus
BACKGROUND: Exenatide extended release (ER) is a glucagon‐like peptide‐1 analogue that increases insulin secretion, inhibits glucagon secretion and induces satiation in humans with type 2 diabetes mellitus. The use of exenatide ER is safe and stimulates insulin secretion in healthy cats. OBJECTIVES:...
Tallennettuna:
| Julkaisussa: | J Vet Intern Med |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4913624/ https://ncbi.nlm.nih.gov/pubmed/26700409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.13817 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|